The European Commission has published a draft adequacy decision to allow the continuation of personal data flows between the EU and the UK after the end of the Brexit transition period.

NIA joined a group of health and pharma organizations in a supporting statement for the draft decision: exchange of data will be fundamental in guaranteeing that researchers on both sides of the Channel can continue to collaborate, especially in light of health threats such as COVID-19.

After formal adoption, the adequacy decision will remain in force for a period of four years.

Read the joint statement here.